908 Devices (MASS) Q2 Revenue Jumps 14%
908 Devices (NASDAQ:MASS), a specialist in handheld chemical analysis devices, reported its second-quarter 2025 financial results on August 5, 2025. Revenue (GAAP) increased to $13.0 million, surpassing Wall Street expectations of $12.17 million. This marked a 14% rise from the prior year’s quarter; profitability remained pressured. Reported GAAP earnings per share came in at $(0.36). Narrower GAAP and non-GAAP (adjusted) gross margins were reported, and a wider net loss, reflecting ongoing investments and restructuring. Overall, the quarter delivered strong top-line growth, with revenue increasing 14% year over year, but also highlighted lingering challenges in operating expenses and margin management.
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report.
908 Devices develops and manufactures portable and handheld chemical analysis instruments. Its core products use miniaturized mass spectrometry (Mass Spec) and related technologies to deliver real-time, in-field chemical identification. These devices are designed for point-of-need use, an advantage over traditional lab-bound equipment. Target users span public safety, law enforcement, military, pharmaceutical, and industrial quality assurance sectors.
Source Fool.com
Target Corp. Stock
The stock is one of the favorites of our community with 26 Buy predictions and 3 Sell predictions.
As a result the target price of 110 € shows a positive potential of 36.92% compared to the current price of 80.34 € for Target Corp..
